A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ
Clinical trial NCT05422482 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05422482
- Sponsor
- GC Biopharma Corp
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2027-06-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.